Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IPAB’s Tough Road Ahead Shown As Republicans Opt Not To Help Find Members

This article was originally published in The Pink Sheet Daily

Executive Summary

House Speaker Boehner and Senate Majority Leader McConnell “respectfully decline” the president’s request to submit names of individuals to serve on the Medicare Independent Payment Advisory Board.

You may also be interested in...



Sens. Hatch, Alexander Expected To Helm Health Panels In Senate

Orrin Hatch, the veteran of major pharmaceutical legislative initiatives, is in line to head the Finance Committee with the change to Republican control of the Senate. The Health, Education, Labor and Pensions Committee – with jurisdiction over biomedical R&D and public health – will be headed by Lamar Alexander, in his first opportunity to chair a committee.

MedPAC Seeks Stakeholder Input On Medicare “Least Costly Alternative” Policy

Comments by members of the Medicare Payment Advisory Commission at a recent meeting suggest an opportunity for pharmaceutical industry stakeholders to help frame the discussion of Medicare value-based payment approaches for Part B drugs.

Tavenner’s Nomination For CMS Will Get Senate Vote As Harkin Lifts Hold

Sen. Harkin said he is lifting his hold on a Senate vote on Marilyn Tavenner’s nomination to head CMS because he recognizes the agency needs a permanent leader as it faces the challenges of implementing the Affordable Care Act’s coverage expansion provisions.

Related Content

Topics

UsernamePublicRestriction

Register

PS075664

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel